These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28241745)

  • 1. Drug voyager: a computational platform for exploring unintended drug action.
    Oh M; Ahn J; Lee T; Jang G; Park C; Yoon Y
    BMC Bioinformatics; 2017 Feb; 18(1):131. PubMed ID: 28241745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PISTON: Predicting drug indications and side effects using topic modeling and natural language processing.
    Jang G; Lee T; Hwang S; Park C; Ahn J; Seo S; Hwang Y; Yoon Y
    J Biomed Inform; 2018 Nov; 87():96-107. PubMed ID: 30268842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs.
    Hosomi K; Fujimoto M; Ushio K; Mao L; Kato J; Takada M
    PLoS One; 2018; 13(10):e0204648. PubMed ID: 30300381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse Events.
    Wang K; Wan M; Wang RS; Weng Z
    J Med Internet Res; 2016 Apr; 18(4):e76. PubMed ID: 27036325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TarPred: a web application for predicting therapeutic and side effect targets of chemical compounds.
    Liu X; Gao Y; Peng J; Xu Y; Wang Y; Zhou N; Xing J; Luo X; Jiang H; Zheng M
    Bioinformatics; 2015 Jun; 31(12):2049-51. PubMed ID: 25686637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Repositioning by Mining Adverse Event Data in ClinicalTrials.gov.
    Su EW
    Methods Mol Biol; 2019; 1903():61-72. PubMed ID: 30547436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.
    Issa NT; Kruger J; Wathieu H; Raja R; Byers SW; Dakshanamurthy S
    BMC Bioinformatics; 2016 May; 17(1):202. PubMed ID: 27151405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the associations between drug side-effects and therapeutic indications.
    Wang F; Zhang P; Cao N; Hu J; Sorrentino R
    J Biomed Inform; 2014 Oct; 51():15-23. PubMed ID: 24727480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development.
    Wilson JL; Racz R; Liu T; Adeniyi O; Sun J; Ramamoorthy A; Pacanowski M; Altman R
    PLoS Comput Biol; 2018 Dec; 14(12):e1006614. PubMed ID: 30532240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using quantitative systems pharmacology for novel drug discovery.
    Pérez-Nueno VI
    Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Drug Repurposing: Current Trends.
    Karaman B; Sippl W
    Curr Med Chem; 2019; 26(28):5389-5409. PubMed ID: 29848268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarity-based prediction for Anatomical Therapeutic Chemical classification of drugs by integrating multiple data sources.
    Liu Z; Guo F; Gu J; Wang Y; Li Y; Wang D; Lu L; Li D; He F
    Bioinformatics; 2015 Jun; 31(11):1788-95. PubMed ID: 25638810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports.
    Hoffman KB; Dimbil M; Tatonetti NP; Kyle RF
    Drug Saf; 2016 Jun; 39(6):561-75. PubMed ID: 26946292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tool to utilize adverse effect profiles to identify brain-active medications for repurposing.
    McCoy TH; Perlis RH
    Int J Neuropsychopharmacol; 2015 Feb; 18(3):. PubMed ID: 25673184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adverse Effect Predictions Based on Computational Toxicology Techniques and Large-scale Databases].
    Uesawa Y
    Yakugaku Zasshi; 2018; 138(2):185-190. PubMed ID: 29386432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities.
    Walker VM; Davey Smith G; Davies NM; Martin RM
    Int J Epidemiol; 2017 Dec; 46(6):2078-2089. PubMed ID: 29040597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mining drug-disease relationships as a complement to medical genetics-based drug repositioning: Where a recommendation system meets genome-wide association studies.
    Wang H; Gu Q; Wei J; Cao Z; Liu Q
    Clin Pharmacol Ther; 2015 May; 97(5):451-4. PubMed ID: 25670647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Analytical Review of Computational Drug Repurposing.
    Sadeghi SS; Keyvanpour MR
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):472-488. PubMed ID: 31403439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic integration of biomedical knowledge prioritizes drugs for repurposing.
    Himmelstein DS; Lizee A; Hessler C; Brueggeman L; Chen SL; Hadley D; Green A; Khankhanian P; Baranzini SE
    Elife; 2017 Sep; 6():. PubMed ID: 28936969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining automatic table classification and relationship extraction in extracting anticancer drug-side effect pairs from full-text articles.
    Xu R; Wang Q
    J Biomed Inform; 2015 Feb; 53():128-35. PubMed ID: 25445920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.